SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
Mar 11, 2016
Document Date
Dec 31, 2015
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS INC